Stillbirth classification-developing an international consensus for research: Executive summary of a national institute of child health and human development workshop

Obstetrics and Gynecology

Volumn 114, Issue 4, 2009, Pages 901-914

  Reddy, Uma M ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Goldenberg, Robert ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Silver, Robert ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Smith, Gordon C S ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Pauli, Richard M ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Wapner, Ronald J ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Gardosi, Jason ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Pinar, Halit ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Grafe, Marjorie ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Kupferminc, Michael ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Hulthén Varli, Ingela ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Erwich, Jan Jaap H M ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Fretts, Ruth C ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Willinger, Marian ^{a,b,c,d,e,f,g,h,i,j,k,l,m}  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b DREXEL UNIVERSITY   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

^f Och Spine at New York Presbyterian Hospitals   (United States)

^g West Midlands Perinatal Institute   (United Kingdom)

^h BROWN UNIVERSITY   (United States)

ⁱ OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^j TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^k KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^l UNIVERSITY OF GRONINGEN   (Netherlands)

^m Harvard Vanguard Medical Association   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALLOIMMUNIZATION; AMNION BAND SYNDROME; ANTIPHOSPHOLIPID SYNDROME; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM DISEASE; CHROMOSOME ABERRATION; CONGENITAL MALFORMATION; CONSENSUS; DIABETES MELLITUS; DISEASE CLASSIFICATION; ERYTHROCYTE; EVIDENCE BASED PRACTICE; FETOMATERNAL TRANSFUSION; HUMAN; HYPERTENSION; INFECTION; INTRAUTERINE GROWTH RETARDATION; INTRAUTERINE INFECTION; KIDNEY DISEASE; LIVER DISEASE; MATERNAL DISEASE; MEDICAL RESEARCH; MOSAICISM; MULTIPLE PREGNANCY; NATIONAL HEALTH ORGANIZATION; NOTE; PATHOLOGY; PATHOPHYSIOLOGY; PLACENTA DISORDER; PREECLAMPSIA; PRIORITY JOURNAL; SOLUTIO PLACENTAE; STILLBIRTH; THROMBOCYTE; THROMBOPHILIA; THYROID DISEASE; UMBILICAL MALFORMATION; UNCERTAINTY; UTERINE COMPLICATION; VASA PREVIA;

FEMALE; FETAL DEATH; HUMANS; PREGNANCY; STILLBIRTH;

EID: 70349668765     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181b8f6e4     Document Type: Note

References (47)

1. Stanton C, Lawn JE, Rahman H, Wilczynska-Ketende K, Hill K. Stillbirth rates: delivering estimates in 190 countries. Lancet 2006;367:1487-1494
2. MacDorman MF, Kirmeyer S. Fetal and perinatal mortality, United States, 2005. National vital statistics reports; vol 57 no 8. Hyattsville (MD): National Center for Health Statistics. 2009.
3. Goldenberg RL, Thompson C. The infectious origins of stillbirth. Am J Obstet Gynecol 2003;189:861-873
4. Hardy JM, Azarowicz EN, Mannini A, Medearis DN Jr, Cooke RE. The effect of Asian influenza on the outcome of pregnancy: Baltimore 1957-1958. Am J Public Health Nations Health 1961;51:1182-1188
5. Horn P. Poliomyelitis in pregnancy: A twenty-year report from Los Angeles County, California. Obstet Gynecol 1955;6: 121-137
6. Steketee RW, Wirima JJ, Slutsker L, Heymann DL, Breman JG. The problem of malaria and malaria control in pregnancy in sub-Saharan Africa. Am J Trop Med Hyg 1996;55(suppl):2-7.
7. Sheffield JS, Sanchez PJ, Wendel GD Jr, Fong DW, Margraf LR, Zeray F, et al. Placental histopathology of congenital syphilis. Obstet Gynecol 2002;100:126-133
8. Plaza MC, Gilbert-Barness E. Fetal death in utero secondary to Listeria monocytogenes placental infection. Pediatr Pathol Mol Med 2001;20:433-437
9. De Santis M, Cavaliere AF, Straface G, Caruso A. Rubella infection in pregnancy. Reprod Toxicol 2006;21:390-398
10. Petersson K, Bremme K, Bottinga R, Hofsjö A, Hulthén-Varli I, Kublickas M, et al. Diagnostic evaluation of intrauterine fetal deaths in Stockholm 1998-1999 [published erratum appears in Acta Obstet Gynecol Scand 2003;82:102]. Acta Obstet Gynecol Scand 2002;81:284-292
11. Ananth CV, Savitz DA, Bowes WA Jr. Hypertensive disorders of pregnancy and stillbirth in North Carolina, 1988 to 1991. Acta Obstet Gynecol Scand 1995;74:788-793
12. Tricomi V, Kohl SG. Fetal death in utero. Am J Obstet Gynecol 1957;74:1092-1097
13. Information and Statistics Division NHS Scotland. Scottish perinatal and infant mortality report 2000 Edinburgh (Scotland): ISD Scotland Publications; 2001.
14. Martin JN Jr, Rinehart BK, May WL, Magann EF, Terrone DA, Blake PG. The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol 1999;180:1373-1384
15. Smulian JC, Ananth CV, Vintzileos AM, Scorza WE, Knuppel RA. Fetal deaths in the United States. Influence of high-risk conditions and implications for management. Obstet Gynecol 2002;100:1183-1189
16. Macintosh MC, Fleming KM, Bailey JA, Doyle P, Modder J, Acolet D, et al. Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: Population based study. BMJ 2006;333:177.
17. Neale D, Burrow G. Thyroid disease in pregnancy. Obstet Gynecol Clin North Am 2004;31:893-905.
18. Simpson LL. Maternal medical disease: Risk of antepartum fetal death. Semin Perinatol 2002;26:42-50.
19. Fischer MJ. Chronic kidney disease and pregnancy: maternal and fetal outcomes. Adv Chronic Kidney Dis 2007;14:132-145
20. Fisk NM, Bye WB, Storey GN. Maternal features of obstetric cholestasis: 20 years experience at King George V Hospital. Aust N Z J Obstet Gynaecol 1988;28:172-176
21. Ko H, Yoshida EM. Acute fatty liver of pregnancy. Can J Gastroenterol 2006;20:25-30.
22. Molad Y. Systemic lupus erythematosus and pregnancy. Curr Opin Obstet Gynecol 2006;18:613-617
23. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
24. Antiphospholipid syndrome. ACOG Practice Bulletin No. 68. American College of Obstetricians and Gynecologists. Obstet Gynecol 2005;106:1113-1121
25. Empson M, Lassere M, Craig J, Scott J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. The Cochrane Database of Systemic Reviews 2005, Issue 2. Art. No.: CD002859. DOI: 10.1002/ 14651858.CD002859.pub2.
26. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: A meta-analysis. Lancet 2003;361:901-908
27. Alfirevic Z, Roberts D, Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol 2002;101:6-14.
28. Lockwood C, Silver R. Thrombophilias in pregnancy. In: Creasy R, Resnick R, Iams J. Maternal-fetal medicine: Principles and practice. 5th ed. Philadelphia (PA): WB Saunders Company; 2003: P. 1005-1022
29. Lindqvist PG, Svensson PJ, Marsaá l K, Grennert L, Luterkort M, Dahlbäck B. Activated protein C resistance (FV:Q506) and pregnancy. Thromb Haemost 1999;81:532-537
30. Dizon-Townson D, Miller C, Sibai B, Spong CY, Thom E, Wendel G Jr, et al. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol 2005;106:517-524
31. Moise KJ. Fetal anemia due to non-Rhesus-D red-cell alloimmunization. Semin Fetal Neonatal Med 2008;13:207-214
32. Kaplan C. Alloimmune thrombocytopenia of the fetus and the newborn. Blood Rev 2002;16:69-72.
33. Pauli RM, Reiser CA, Lebovitz RM, Kirkpatrick SJ. Wisconsin Stillbirth Service Program: I. Establishment and assessment of a community-based program for etiologic investigation of intrauterine deaths. Am J Med Genet 1994;50:116-134
34. Pauli RM, Reiser CA. Wisconsin Stillbirth Service Program: II. Analysis of diagnoses and diagnostic categories in the first 1,000 referrals. Am J Med Genet 1994;50:135-153
35. Korteweg FJ, Bouman K, Erwich JJ, Timmer A, Veeger NJ, Ravise JM, et al. Cytogenetic analysis after evaluation of 750 fetal deaths: Proposal for diagnostic workup. Obstet Gynecol 2008;111:865-874
36. Wapner RJ, Lewis D. Genetics and metabolic causes of stillbirth. Semin Perinatol 2002;26:70-74
37. Won RH, Currier RJ, Lorey F, Towner DR. The timing of demise in fetuses with trisomy 21 and trisomy 18. Prenat Diagn 2005;25:608-611
38. Shaffer LG, Coppinger J, Alliman S, Torchia BA, Theisen A, Ballif BC, et al. Comparison of microarray-based detection rates for cytogenetic abnormalities in prenatal and neonatal specimens. Prenat Diagn 2008;28:789-795
39. Kalousek DK, Barrett IJ, McGillivray BC. Placental mosaicism and intrauterine survival of trisomies 13 and 18. Am J Hum Genet 1989;44:338-343
40. Benn P. Trisomy 16 and trisomy 16 Mosaicism: A review. Am J Med Genet 1998;79:121-133
41. Laube DW, Schauberger CW. Fetomaternal bleeding as a cause for "unexplained" fetal death. Obstet Gynecol 1982;60: 649-651
42. Marions L, Thomassen P. Six cases of massive feto-maternal bleeding causing intra-uterine fetal death. Acta Obstet Gynecol Scand 1991;70:85-88
43. Samadi R, Greenspoon JS, Gviazda I, Settlage RH, Goodwin TM. Massive fetomaternal hemorrhage and fetal death: Are they predictable? J Perinatol 1999;19:227-229
44. Sebring ES, Polesky HF. Fetomaternal hemorrhage: Incidence, risk factors, time of occurrence, and clinical effects. Transfusion 1990;30:344-357
45. Cohen F, Zuelzer WW, Gustafson DC, Evans MM. Mechanisms of isoimmunization. I. The transplacental passage of fetal erythrocytes in homospecific pregnancies. Blood 1964;23: 621-646
46. Dziegiel MH, Nielsen LK, Berkowicz A. Detecting fetomaternal hemorrhage by flow cytometry. Curr Opin Hematol 2006;13:490-495
47. Rubod C, Deruelle P, Le Goueff F, Tunez V, Fournier M, Subtil D. Long-term prognosis for infants after massive fetomaternal hemorrhage. Obstet Gynecol 2007;110:256-260